Neutrogena Faces Boycott Calls After Hayden Panettiere’s Tragic Death — Here’s What Sparked the Backlash

The death of actress Hayden Panettiere at just 36 has left fans grieving—and it has also reignited a controversy involving one of the beauty industry’s best-known brands.

Panettiere died on August 16, 2026, after being found unresponsive in South Carolina. Authorities have said there were no signs of trauma, while the investigation into the cause of death remains ongoing.

But amid the tributes, an old dispute between Panettiere and Neutrogena has suddenly returned to the spotlight.

Why Are Fans Angry at Neutrogena?

Panettiere had a long relationship with Neutrogena, becoming one of the brand’s recognizable celebrity ambassadors.

The controversy centers on comments she made publicly about her experience with postpartum depression following the birth of her daughter.

In a 2015 television appearance, Panettiere openly discussed postpartum depression and emphasized that women needed support and understanding. Years later, while discussing her memoir, she said Neutrogena had wanted to end their relationship after she spoke publicly about the issue.

Panettiere characterized the situation as particularly painful because the brand had supported her for years. She said she believed the decision was connected to a morals clause in her contract.

Those comments have now resurfaced following her death.

Social Media Erupts

As news of Panettiere’s passing spread, fans began revisiting interviews in which she discussed the experience.

Calls to boycott Neutrogena appeared across social-media platforms, with some users saying they would no longer purchase the company’s products.

The reaction has been emotional, with many fans arguing that Panettiere should have been supported rather than criticized for speaking honestly about postpartum depression.

However, it is important to distinguish Panettiere’s account from an independently established finding. Her statements describe her understanding of what happened; they do not establish that Neutrogena legally violated any agreement or that the company ended the relationship specifically because of her medical condition.

Did Neutrogena’s Stock Really “Spiral”?

This is where the viral headline needs some context.

Neutrogena itself isn’t a separately traded public company. It is owned by Kenvue, the consumer-health company whose portfolio includes Neutrogena.

Kenvue’s shares did fall about 2% on August 17 amid the renewed controversy, according to reports. But describing that movement as the company’s stock “spiraling because of Hayden Panettiere” goes further than the available evidence supports. A single day’s share-price movement can have many causes, and there is no established evidence proving that the boycott calls alone caused the decline.

A Conversation Bigger Than a Beauty Brand

At the center of the controversy is something much more serious than advertising contracts.

Panettiere spent years speaking about difficult experiences that many women face but may hesitate to discuss publicly.

Postpartum depression can be frightening, isolating and deeply misunderstood. Panettiere’s willingness to discuss her own experience helped bring attention to an issue that is often hidden behind expectations of motherhood.

Her death has caused many people to revisit those conversations.

For fans, the question isn’t simply whether they should buy a particular skincare product.

It’s whether companies should stand behind public figures when those figures choose to speak honestly about difficult experiences.

Hayden Panettiere’s Legacy

Panettiere became famous at a young age and went on to star in Heroes, Nashville and the Scream franchise.

She also used her public platform to discuss addiction, postpartum depression and the pressures of growing up in the entertainment industry. Her family confirmed her death at age 36, and tributes have poured in from colleagues and fans.

Her death has left many people asking what more could have been done to support her.

For now, the investigation into her death continues, and the final cause has not been established.

At the same time, the renewed Neutrogena controversy continues to unfold online.

Whether the boycott calls will have any lasting effect on the brand remains to be seen.

But one thing is clear: Hayden Panettiere’s story has reopened an important conversation about postpartum depression, mental health, celebrity contracts and what happens when someone chooses to speak openly about their struggles.

Whatever people think about the controversy, her death is first and foremost a heartbreaking loss of a woman who touched millions of lives through her work.

This article distinguishes reported facts from claims and online reactions; the investigation into Panettiere’s death remains ongoing.